AngioDynamics Inc reports results for the quarter ended in August - Earnings Summary

AngioDynamics

04/10/2023 14:30

* AngioDynamics Inc  ANGO.OQ  reported a quarterly adjusted
loss
of 12 cents​​ per share for the quarter ended in August. The
mean expectation of four analysts for the quarter was for a loss
of 13 cents per share.
    * Revenue fell 3.5% to $78.68 million from a year ago;
analysts
expected $77.69 million. 
    * AngioDynamics Inc's reported EPS for the quarter was 15
cents​.
    * The mean earnings estimate of analysts had fallen by
about 85.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * AngioDynamics Inc shares had risen by 4.0% this
quarter and
lost 44.8% so far this year.
    * The company reported quarterly net income of $45.88
million.
    * Wall Street's median 12-month price target for
AngioDynamics Inc
is $19.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
October 4 at 01:30 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Aug. 31 2023      -0.13          -0.12          Beat
 May. 31 2023      0.02           0.02           Met
 Feb. 28 2023      -0.01          -0.03          Missed
 Nov. 30 2022      -0.01          0.01           Beat